Followers | 275 |
Posts | 55881 |
Boards Moderated | 24 |
Alias Born | 08/29/2007 |
Thursday, October 12, 2023 1:28:09 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent ACXP News
- Acurx Announces New Bile Acid and Microbiome Analyses from Ph2b Trial of Ibezapolstat in CDI Patients Presented at IDWeek Scientific Conference • PR Newswire (US) • 10/21/2024 11:00:00 AM
- Acurx Pharmaceuticals Announces Participation at The Spartan Capital Investor Conference to Showcase Growth Companies and Foster High-Level Investor Engagement • PR Newswire (US) • 10/17/2024 12:00:00 PM
- Acurx Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 13, 2024 • PR Newswire (US) • 10/16/2024 12:00:00 PM
- Acurx Announces Additional Ibezapolstat Ph2b Results in CDI as well as Anthrax (B. anthracis) Susceptibility to ACX-375 Analogues • PR Newswire (US) • 09/26/2024 11:00:00 AM
- Acurx Announces Results of Its Pioneering Research with Ibezapolstat in Collaboration with Leiden University Medical Center at the Premier International C. difficile Symposium • PR Newswire (US) • 09/24/2024 11:00:00 AM
- New to The Street Announces its Five Corporate Interviews, Airing Episode 591 on the Fox Business Network, Tonight Monday, August 26, 2024, at 10:30 PM PT • GlobeNewswire Inc. • 08/26/2024 01:15:00 PM
- ACURX PHARMACEUTICALS ANNOUNCES PARTICIPATION AT THE H.C. Wainwright 26th Annual Global Investment Conference • PR Newswire (US) • 08/26/2024 11:00:00 AM
- New to The Street Announces Episode 590, Five Corporate Interviews, Airing on the Fox Business Network, Tonight Monday, August 19, 2024, at 10:30 PM PT • GlobeNewswire Inc. • 08/19/2024 01:20:00 PM
- New to The Street TV Announces Episode 583, Five Riveting Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Saturday, August 10, 2024, at 6:30 PM ET • GlobeNewswire Inc. • 08/09/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 11:13:16 AM
- Acurx Pharmaceuticals, Inc. Reports Second Quarter 2024 Results and Provides Business Update • PR Newswire (US) • 08/09/2024 11:01:00 AM
- USPTO Grants Acurx Pharmaceuticals New Patent for Ibezapolstat to Treat CDI While Reducing Recurrence of Infection and Improving Health of the Gut Microbiome • PR Newswire (US) • 07/17/2024 11:00:00 AM
- Acurx Pharmaceuticals, Inc. to Discuss Second Quarter 2024 Financial Results on August 9, 2024 Conference Call and Provide Business Update • PR Newswire (US) • 07/16/2024 11:00:00 AM
- Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results for CDI at Scientific Conference • PR Newswire (US) • 07/15/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 08:14:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 08:11:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 08:14:40 PM
- New to The Street Announces Episode 576, Four Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Tonight, Thursday, June 6, 2024, at 9:30 PM PT • GlobeNewswire Inc. • 06/06/2024 01:30:00 PM
- Acurx Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection • PR Newswire (US) • 05/15/2024 01:00:00 PM
- U.S. Index Futures Flat Ahead of April CPI Data Release, Oil Prices Drop • IH Market News • 05/15/2024 11:50:05 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 11:13:05 AM
- Acurx Pharmaceuticals, Inc. Reports First Quarter 2024 Results and Provides Business Update • PR Newswire (US) • 05/15/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:05:29 PM
- Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific Conference • PR Newswire (US) • 05/02/2024 11:00:00 AM
- Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference • PR Newswire (US) • 04/25/2024 02:12:00 PM
FEATURED North Bay Resources Announces Federal (MSHA) Approval of Mt. Vernon Gold Mine Operational Plan and Commencement of Production, Sierra County, California • Oct 21, 2024 9:00 AM
Hydromer, Inc. Announces the Restructuring and Formation of World-Class Research and Development Division to Drive Innovation and New Product Development • HYDI • Oct 21, 2024 9:00 AM
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM